| Pictorial Representation of Illness and Self Measure (NCT01707186) | University of Oxford | 2012-10-18 |
| Assessment of Clinical Effectiveness and Safety of Adalimumab and High Dose Methotrexate in Routine Clinical Practice (NCT01736189) | AbbVie (prior sponsor, Abbott) | 2012-10-11 |
| A Nutrition Intervention for Arthritis -2 (NCT01700881) | Physicians Committee for Responsible Medicine | 2012-10-01 |
| Secukinumab Efficacy and Safety Study in Patients With Rheumatoid Arthritis and Inadequate Response to Anti-TNFα Agents. (NCT01770379) | Novartis Pharmaceuticals | 2012-10-01 |
| A Study in Moderate to Severe Rheumatoid Arthritis (NCT01710358) | Eli Lilly and Company | 2012-10-01 |
| Pain Evaluation in Rheumatoid Arthritis (NCT01706029) | University Hospital, Limoges | 2012-10-01 |
| Doppler Evaluation in RA Patients After Adalimumab. (NCT01609205) | Hamed Rezaei | 2012-10-01 |
| Acupuncture Study on Rheumatoid Arthritis, Monitoring Microbiome and Blood (NCT01619176) | Chinese Academy of Sciences | 2012-10-01 |
| A Long-Term Extension Study of RoActemra/Actemra (Tocilizumab) in Patients With Early Moderate to Severe Rheumatoid Arthritis Who Completed Study WA19926 (NCT01730456) | Hoffmann-La Roche | 2012-10-01 |
| Study to Evaluate and Compare Safety and Pharmacokinetics of the HCP1004 and VIMOVO 500/20mg in Healthy Korean Male (NCT01688193) | Hanmi Pharmaceutical Company Limited | 2012-10-01 |
| 25-hydroxyvitamin D and Fatigue: The VITALITY Study (NCT01718925) | Ostfold Hospital Trust | 2012-10-01 |
| A Long-Term Extension Study of WA22762 to Evaluate Safety and Efficacy of Subcutaneous Tocilizumab in Participants With Moderate to Severe Rheumatoid Arthritis (RA). (NCT01734993) | Hoffmann-La Roche | 2012-10-01 |
| The Medacta International GMK Sphere Post-Marketing Surveillance Study (NCT02199600) | Medacta International SA | 2012-10-01 |
| Kineret in the Treatment of Rheumatoid Arthritis (NCT02915094) | Swedish Orphan Biovitrum | 2012-10-01 |
| Sidus(TM) Post Market Clinical Follow-up (PMCF) Study (NCT01700543) | Zimmer Biomet | 2012-10-01 |
| To Evaluate The Effect Of SAR153191 (REGN88) Added To Other RA Drugs In Patients With RA Who Are Not Responding To Or Intolerant Of Anti-TNF Therapy (SARIL-RA-TARGET) (NCT01709578) | Sanofi | 2012-10-01 |
| Investigation of the Safety and Efficacy of Iguratimod in Patients With Rheumatoid Arthritis (NCT01850966) | Eisai Co., Ltd. | 2012-09-12 |
| A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Assess Clinical Efficacy of NNC0114-0006 in Subjects With Active Rheumatoid Arthritis (NCT01647451) | Novo Nordisk A/S | 2012-09-01 |
| Comparison the Safety and Pharmacokinetic Characteristics of DWP422 25 mg With Those of ENBREL 25MG PFS INJ. After Subcutaneous Injection in Healthy Male Volunteers (NCT01635686) | Daewoong Pharmaceutical Co. LTD. | 2012-09-01 |
| A Study of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate in Patients With Severe Active Rheumatoid Arthritis, Comparing Tapering Versus Maintaining the Methotrexate Dosage (NCT01661140) | Hoffmann-La Roche | 2012-09-01 |
| A Non-Interventional Study in Patients With Rheumatoid Arthritis Who Are Treated With RoActemra/Actemra (Tocilizumab) (NCT01893255) | Hoffmann-La Roche | 2012-09-01 |
| Study of Anti-Viral Prophylaxis for HBsAg(+) or HBcAb(+)/HBsAb(-) Patients Starting Anti-TNFα (NCT01694264) | Seoul National University Hospital | 2012-09-01 |
| Evaluation of Tabalumab Using Auto-Injector or Prefilled Syringe in Participants With Rheumatoid Arthritis (RA) (NCT01676701) | Eli Lilly and Company | 2012-09-01 |
| A Retrospective Chart Review on the Use of Biologics in Monotherapy for the Treatment of Patients With Rheumatoid Arthritis (NCT01640548) | Hoffmann-La Roche | 2012-09-01 |
| A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Trial to Evaluate the Safety, Tolerability, and Efficacy of MK-8457 in Participants With Rheumatoid Arthritis (MK-8457-010) (NCT01651936) | Merck Sharp & Dohme LLC | 2012-08-29 |
| Rheumatoid Arthritis Extension Trial For Subjects Who Have Participated In Other PF-05280586 Trials (REFLECTIONS B328-04) (NCT01643928) | Pfizer | 2012-08-16 |
| A Study of the Pharmacokinetics and Safety of SM03 in Patients With Rheumatoid Arthritis (NCT04704492) | SinoMab BioScience Ltd | 2012-08-14 |
| A Long-Term Extension Study of WA22762 and NA25220 of Subcutaneous (SC) Tocilizumab (TCZ) in Moderate to Severe Rheumatoid Arthritis (RA) (NCT01662063) | Genentech, Inc. | 2012-08-01 |
| Oral Health Assessment in Rheumatoid Arthritis and Other Autoimmune Diseases-- Anti- TNF Substudy (NCT01698515) | Johns Hopkins University | 2012-08-01 |
| A Non-Interventional Study of RoActemra/Actemra (Tocilizumab) in Monotherapy in Patients With Rheumatoid Arthritis (MONACO) (NCT01643863) | Hoffmann-La Roche | 2012-08-01 |
| Inflammation and the Heart (NCT01589770) | Vanderbilt University | 2012-08-01 |
| A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Anti-TNFa Biologics (NCT01636817) | Novo Nordisk A/S | 2012-08-01 |
| Special Drug Use-Results Survey of Prograf Capsule in Rheumatoid Arthritis Patients (NCT01870908) | Astellas Pharma Inc | 2012-08-01 |
| Efficacy and Safety Study of Tacrobell to Treat Rheumatoid Arthritis (NCT01746680) | Chong Kun Dang Pharmaceutical | 2012-08-01 |
| BIIB057 in Subjects With Rheumatoid Arthritis and Inadequate Response to Disease-Modifying Antirheumatic Drugs (NCT01652937) | Biogen | 2012-08-01 |
| A Study of Mavrilimumab in Subjects With Moderate-to-Severe Rheumatoid Arthritis (NCT01706926) | MedImmune LLC | 2012-08-01 |
| A Non-Interventional Study of Rheumatoid Arthritis Patients Treated With RoActemra/Actemra (Tocilizumab) in Monotherapy (NCT01705730) | Hoffmann-La Roche | 2012-07-31 |
| Regulatory B Cells in Inflammatory Rheumatisms and Biomarkers of Response to Biologic Treatments (NCT01642706) | University Hospital, Montpellier | 2012-07-02 |
| A Non-Interventional Study of RoActemra/Actemra in Patients With Moderate to Severe Rheumatoid Arthritis (NCT01672970) | Hoffmann-La Roche | 2012-07-01 |
| Study Conducted in Subjects With Rheumatoid Arthritis Who Have Moderate to Severe Disease Activity Despite Methotrexate Therapy With or Without Other Non Biologic Disease Modifying Antirheumatic Drugs (DMARDs)for at Least 12 Weeks Prior to Screening (NCT01578850) | Pfizer | 2012-07-01 |
| A Long-Term Extension Study to WA19926 (NCT01007435) of Tocilizumab in Participants With Early, Moderate to Severe Rheumatoid Arthritis (NCT01665430) | Hoffmann-La Roche | 2012-07-01 |
| Effectiveness of Iguratimod Versus Placebo to Treat Early Rheumatoid Arthritis on MRI (NCT01893151) | Jiangsu Simcere Pharmaceutical Co., Ltd. | 2012-07-01 |
| A Non-Interventional Study Evaluating Rheumatoid Arthritis Participants Treated With Tocilizumab (RoActemra/Actemra) (NCT01671059) | Hoffmann-La Roche | 2012-07-01 |
| A Prospective Munti-center Study on VANGUARD™ PS Total Knee Replacement System (NCT01906177) | Zimmer Biomet | 2012-07-01 |
| Leflunomide Versus Sulfasalazine/Methotrexate in Rheumatoid Arthritis:an Ultrasound/Magnetic Resonance Imaging Study (NCT01659242) | Singapore General Hospital | 2012-07-01 |
| Painless Synovitis in Patients With Longstanding Rheumatoid Arthritis (NCT01639287) | Federal University of São Paulo | 2012-07-01 |
| A Long Term Study to Assess the Safety of Fostamatinib in Patients in Asia With Rheumatoid Arthritis (NCT01640054) | AstraZeneca | 2012-07-01 |
| A Long-Term Safety Extension Study of WA19926 in Participants With Rheumatoid Arthritis (NCT01649804) | Hoffmann-La Roche | 2012-07-01 |
| First Human Dose Trial of NNC0215-0384 in Subjects With Rheumatoid Arthritis (NCT01611688) | Novo Nordisk A/S | 2012-06-04 |
| Home Based Computer Gaming Hand Exercise Regimen for People With Arthritis Affecting the Hands (NCT01635582) | University of Manitoba | 2012-06-01 |
| A Study in Rheumatoid Arthritis (RA) Patients to Compare Two Formulations of Adalimumab for Pharmacokinetic, Pharmacodynamic and Safety (NCT01712178) | AbbVie (prior sponsor, Abbott) | 2012-06-01 |
| An Observational Study in Clinical Practice Management of Patients With Biological Drugs in Monotherapy (NCT01664117) | Hoffmann-La Roche | 2012-06-01 |
| A Study to Evaluate Tocilizumab Treatment in a Real-Life Setting (NCT01664104) | Hoffmann-La Roche | 2012-06-01 |
| Phase IIB Dose Ranging Study in Subjects With Moderate to Severe Rheumatoid Arthritis (NCT02015520) | CSL Behring | 2012-06-01 |
| A Clinical Evaluation of Metal Ion Release From Metal-on-Metal Cementless Total Hip Arthroplasty (NCT00757354) | Zimmer Biomet | 2012-06-01 |
| Ultrasound and Withdrawal of Biological DMARDs in Rheumatoid Arthritis (NCT01602302) | Medical University of Graz | 2012-06-01 |
| A Study To Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of ASP2408 After Multiple Dose Subcutaneous Injections in Patients With Rheumatoid Arthritis on Methotrexate (NCT02052375) | Astellas Pharma Global Development, Inc. | 2012-06-01 |
| Yoga as Self-Care for Arthritis in Minority Communities (NCT01617421) | National Institutes of Health Clinical Center (CC) | 2012-05-31 |
| A Study of Iguratimod in Patients With Active Rheumatoid Arthritis (NCT01554917) | Jiangsu Simcere Pharmaceutical Co., Ltd. | 2012-05-01 |
| An Extension Study of WA19926 of the Long-Term Safety of Tocilizumab (RoActemra/Actemra) in Patients With Early Moderate to Severe Rheumatoid Arthritis (NCT01664598) | Hoffmann-La Roche | 2012-05-01 |
| A Retrospective Observational Study on Compliance in Patients With Rheumatoid Arthritis on Treatment With RoActemra/Actemra (Tocilizumab) in Clinical Practice (REMISSION II) (NCT01649817) | Hoffmann-La Roche | 2012-05-01 |
| A Study of LY2127399 in Rheumatoid Arthritis (NCT01576549) | Eli Lilly and Company | 2012-05-01 |
| An Observational Study of RoActemra/Actemra (Tocilizumab) in Rheumatoid Arthritis Patients (NCT01615419) | Hoffmann-La Roche | 2012-05-01 |
| Disease-Modifying Antirheumatic Drugs Cycle Combination Therapy Research (NCT01617590) | Shanxi Medical University | 2012-05-01 |
| Corticosteroids and Anti TNF in Methotrexate Inadequate Responder Rheumatoid Arthritis Patient (NCT01724268) | Hamad Medical Corporation | 2012-05-01 |
| Resistance Exercise in Rheumatic Disease (NCT01599260) | Johns Hopkins University | 2012-05-01 |
| Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis (NCT01579006) | Hoffmann-La Roche | 2012-05-01 |
| Dose-ranging Study With GLPG0634 in Methotrexate-refractory Active Rheumatoid Arthritis Patients (NCT01668641) | Lakefront Biotherapeutics NV | 2012-05-01 |
| Long-term Efficacy of Iguratimod Alone or Iguratimod in Combination With Methotrexate in Patients With Rheumatoid Arthritis (NCT01548001) | Jiangsu Simcere Pharmaceutical Co., Ltd. | 2012-05-01 |
| U-Act-After: An Observational Study on Long-Term Efficacy of Tight Control RoActemra/Actemra (Tocilizumab) and/or Methotrexate in Patients With Early Rheumatoid Arthritis Who Have Participated in the U-Act-Early Study (ML22497) (NCT01918267) | Hoffmann-La Roche | 2012-04-10 |
| A Dose Escalation Study to Assess Safety, Tolerability and Pharmacokinetics of ASP2409 Following a Single Intravenous Dose in Patients With Rheumatoid Arthritis on Methotrexate (NCT02171143) | Astellas Pharma Global Development, Inc. | 2012-04-01 |
| TOward the Lowest Effective DOse of Abatacept or Tocilizumab (NCT01557374) | Assistance Publique - Hôpitaux de Paris | 2012-04-01 |
| Study of Different Doses of Folic Acid in Combination With Methotrexate in Rheumatoid Arthritis (NCT01583959) | Post Graduate Institute of Medical Education and Research, Chandigarh | 2012-04-01 |
| A Non-Interventional Study in Patients With Moderate to Severe Rheumatoid Arthritis Treated With RoActemra/Actemra (Tocilizumab) (NCT01663506) | Hoffmann-La Roche | 2012-04-01 |
| Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid Arthritis (NCT01563978) | AstraZeneca | 2012-04-01 |
| The Usefulness of Interferon-γ Release Assays and Tuberculin Skin Test for Detection of Latent Tuberculosis Infection (NCT01685905) | Hanyang University | 2012-04-01 |
| A Long-Term Extension Study of WA19926 on the Safety of Tocilizumab (RoActemra/Actemra) in Participants With Early Moderate to Severe Rheumatoid Arthritis (NCT01655381) | Hoffmann-La Roche | 2012-04-01 |
| 24-week Study With Open Label Extension of VX-509, an Oral JAK3 Inhibitor, in Subjects Taking Methotrexate (NCT01590459) | Vertex Pharmaceuticals Incorporated | 2012-04-01 |
| An Observational Study of RoActemra/Actemra (Tocilizumab) in Monotherapy in Patients With Rheumatoid Arthritis (NCT01669902) | Hoffmann-La Roche | 2012-04-01 |
| Evaluation of Safety and Effectiveness of Fostamatinib Compared to Placebo in Patients in Asia With Rheumatoid Arthritis (NCT01569074) | AstraZeneca | 2012-04-01 |
| A Pharmacokinetic/Pharmacodynamic Study Comparing PF-05280586 To Rituximab In Subjects With Active Rheumatoid Arthritis With An Inadequate Response To TNF Inhibitors (REFLECTIONS B328-01) (NCT01526057) | Pfizer | 2012-03-20 |
| OTIS Cimzia Pregnancy Registry (NCT01797224) | University of California, San Diego | 2012-03-01 |
| A Non-Interventional Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Rheumatoid Arthritis (NCT01670045) | Hoffmann-La Roche | 2012-03-01 |
| Crossover Study of Safety and Tolerability of Two Formulations of Adalimumab. (NCT01561313) | AbbVie (prior sponsor, Abbott) | 2012-03-01 |
| Long Term Safety Trial of z102 and Prednisone in Patients With Moderate to Severe Rheumatoid Arthritis (NCT01612377) | Zalicus | 2012-03-01 |
| An Extension Study to Demonstrate Long-Term Efficacy and Safety of CT-P13 When Co-administered With Methotrexate in Patient With Rheumatoid Arthritis Who Were Treated With Infliximab (Remicade or CT-P13) in Study CT-P13 3.1 (NCT01571219) | Celltrion | 2012-03-01 |
| Safety and Tolerability of NNC0114-0006 at Increasing Dose Levels in Subjects With Rheumatoid Arthritis (NCT01565408) | Novo Nordisk A/S | 2012-03-01 |
| Use of Cross-linked Donor Corneas as Carriers for the Boston Keratoprosthesis (NCT01582880) | Joseph B. Ciolino, MD | 2012-03-01 |
| Assessment of NSAID-treated Patients Adherence to Co-prescribed Proton Pump Inhibitor (PPI) (NCT01519375) | AstraZeneca | 2012-03-01 |
| An Observational Study in Rheumatoid Arthritis Patients Treated With RoActemra/Actemra (Tocilizumab) (NCT01565122) | Hoffmann-La Roche | 2012-03-01 |
| A Study Exploring the Safety, Tolerability, and Efficacy of a 28 Day Course Followed by an Additional 56 Day Course of Itacitinib in Subjects With Active Rheumatoid Arthritis (NCT01626573) | Incyte Corporation | 2012-03-01 |
| Study of the Articular Microbiota in Rheumatoid Arthritis. (NCT04056234) | University Hospital, Bordeaux | 2012-02-21 |
| Is Fluidotherapy Effective in Rheumatoid Hand? (NCT03127969) | Selmin Gulbahar | 2012-02-16 |
| Study of NI-071 in Comparison With Remicade in Patients With Rheumatoid Arthritis (NCT01567358) | Nichi-Iko Pharmaceutical Co., Ltd. | 2012-02-01 |
| A Study of RoActemra/Actemra (Tocilizumab) With or Without Methotrexate in Patients With Mild to Moderate Rheumatoid Arthritis With an Inadequate Response to Methotrexate (NCT01587989) | Hoffmann-La Roche | 2012-02-01 |
| Prospective Evaluation of the Radiographic Efficacy of Enbrel (NCT01623752) | Pfizer | 2012-02-01 |
| Demonstrate the Equivalence of CT-P10 to MabThera With Respect to the Pharmacokinetic Profile in Patients With Rheumatoid Arthritis (NCT01534884) | Celltrion | 2012-02-01 |
| A Non-Interventional Study in Rheumatoid Arthritis Patients Treated With Tocilizumab (RoActemra/Actemra) (NCT01613378) | Hoffmann-La Roche | 2012-02-01 |
| Impact Of RA Therapy Compliance On Patient-Reported Outcomes (NCT01438892) | Pfizer | 2012-02-01 |
| Diagnostic Value of Oral Prednisolone Test for Rheumatoid Arthritis (NCT01395251) | Rheumazentrum Ruhrgebiet | 2012-02-01 |